- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Targeting higher intraoperative BP does not prevent postoperative MACE: Study
Switzerland: According to a recent study, universally targeting higher intraoperative blood pressures in patients at cardiovascular (CV) risk undergoing major noncardiac surgery may not reduce postoperative complications.
The study, published in the Journal of the American College of Cardiology (JACC) found that despite a 60% reduction in hypotensive time with MAP <65 mm Hg, there were no significant reductions in acute myocardial injury or 30-day major adverse cardiovascular events (MACE)/ acute kidney injury (AKI).
Intraoperative arterial hypotension is known to be strongly associated with postoperative MACE; however, it is not clear whether targeting higher intraoperative mean arterial blood pressures (MAPs) may prevent adverse events. Patrick M.Wanner, University Hospital Basel, Basel, Switzerland, and colleagues aimed to determine whether targeting higher intraoperative MAP lowers the incidence of postoperative MACE.
For this purpose, the researchers designed a single-center randomized controlled trial. It included adult patients at cardiovascular risk undergoing major noncardiac surgery. 458 patients were assigned to an intraoperative MAP target of ≥60 mm Hg (control) or ≥75 mm Hg (MAP ≥75).
The primary outcome was an acute myocardial injury on postoperative days 0-3 and/or 30-day MACE/acute kidney injury (AKI) (acute coronary syndrome, congestive heart failure, coronary revascularization, stroke, AKI, and all-cause mortality). The secondary outcome was 1-year MACE.
Key findings include:
- The cumulative intraoperative duration with MAP <65 mm Hg was significantly shorter in the MAP ≥75 group (median 9 minutes' vs 23 minutes).
- The primary outcome incidence was 48% for MAP ≥75 and 52% for control (risk difference −4.2%), the primary contributor being AKI (incidence 44%).
- Acute myocardial injury occurred in 15% (MAP ≥75) and 19% (control) of patients.
- The secondary outcome incidence was 17% for MAP ≥75 and 15% for control (risk difference +2.7).
"These findings do not support universally targeting higher intraoperative blood pressures to reduce postoperative complications," concluded the authors. "However, there is a need for further studies examining the interplay of intraoperative hypotension, perioperative hemodynamic intervention, and postoperative outcomes with a focus on individualization."
Reference:
The study titled, "Targeting Higher Intraoperative Blood Pressures Does Not Reduce Adverse Cardiovascular Events Following Noncardiac Surgery," is published in the Journal of the American College of Cardiology (JACC).
DOI: https://www.sciencedirect.com/science/article/pii/S0735109721061118
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751